PG de Groot, B de Laat - Best Practice & Research Clinical Rheumatology, 2017 - Elsevier
The presence of antiphospholipid antibodies is one of the most common acquired risk factors for thrombosis. Antiphospholipid antibodies is a collective term for a set of …
N Melas - Thrombosis Update, 2021 - ncbi.nlm.nih.gov
With the implementation of a global vaccination plan, the year 2021 began with the hope of definitively conquering the coronavirus disease 2019 (COVID-19) pandemic. The European …
D Juárez-Melchor, P Munguía-Realpozo… - Reumatología clínica, 2022 - Elsevier
El propósito de esta revisión es presentar los principales aspectos del componente genético de las enfermedades reumatológicas autoinmunes, incluyendo las características del …
SN Siagian, C Christianto - Journal of Medical Case Reports, 2024 - Springer
Background Acute coronary syndrome (ACS) in young women is poorly understood due to underdiagnosis and undertreatment. One of the possible risk factors for ACS in young …
D Juárez-Melchor, P Munguía-Realpozo… - … Clínica (English Edition), 2022 - Elsevier
The purpose of this review is to present the main aspects of the genetic component of autoimmune rheumatic diseases, including the characteristics of the multifactorial or …
Dear Editor, Initially, the UK COVID-19 distribution strategy for the viral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), was to deliver a single dose to the entire population …
PG de Groot, B de Laat - Best Practice & Research Clinical …, 2017 - academia.edu
abstract The presence of antiphospholipid antibodies is one of the most common acquired risk factors for thrombosis. Antiphospholipid antibodies is a collective term for a set of …
E Toubi - ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016 - ima.org.il
High levels of circulating microvesicles (MVs), namely annexin V-bearing MVs, endothelial and platelet MVs, have been associated with an increased risk of thrombosis. An increased …